Annual CFF
$8.76 M
-$10.00 K-0.11%
December 31, 2023
Summary
- As of February 7, 2025, ENSC annual cash flow from financing activities is $8.76 million, with the most recent change of -$10.00 thousand (-0.11%) on December 31, 2023.
- During the last 3 years, ENSC annual CFF has risen by +$7.66 million (+695.99%).
- ENSC annual CFF is now -56.89% below its all-time high of $20.31 million, reached on December 31, 2021.
Performance
ENSC Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$4.13 M
+$4.18 M+8167.77%
September 30, 2024
Summary
- As of February 7, 2025, ENSC quarterly cash flow from financing activities is $4.13 million, with the most recent change of +$4.18 million (+8167.77%) on September 30, 2024.
- Over the past year, ENSC quarterly CFF has increased by +$2.67 million (+182.71%).
- ENSC quarterly CFF is now -55.04% below its all-time high of $9.19 million, reached on December 31, 2021.
Performance
ENSC Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$11.23 M
+$4.23 M+60.50%
September 30, 2024
Summary
- As of February 7, 2025, ENSC TTM cash flow from financing activities is $11.23 million, with the most recent change of +$4.23 million (+60.50%) on September 30, 2024.
- Over the past year, ENSC TTM CFF has increased by +$2.47 million (+28.25%).
- ENSC TTM CFF is now -44.72% below its all-time high of $20.31 million, reached on December 31, 2021.
Performance
ENSC TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
ENSC Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.1% | +182.7% | +28.3% |
| 3 y3 years | +696.0% | +182.7% | +28.3% |
| 5 y5 years | +696.0% | +182.7% | +28.3% |
ENSC Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -56.9% | at low | -55.0% | +1155.6% | -44.7% | +60.5% |
| 5 y | 5-year | -56.9% | +696.0% | -55.0% | +1155.6% | -44.7% | +1732.2% |
| alltime | all time | -56.9% | +696.0% | -55.0% | +1155.6% | -44.7% | +1732.2% |
Ensysce Biosciences Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $4.13 M(-8167.8%) | $11.23 M(+60.5%) |
| Jun 2024 | - | -$51.20 K(-100.9%) | $7.00 M(-44.3%) |
| Mar 2024 | - | $5.69 M(+289.4%) | $12.57 M(+43.6%) |
| Dec 2023 | $8.76 M(-0.1%) | $1.46 M(-1525.5%) | $8.76 M(-5.2%) |
| Sep 2023 | - | -$102.50 K(-101.9%) | $9.23 M(-45.1%) |
| Jun 2023 | - | $5.52 M(+194.5%) | $16.82 M(+52.5%) |
| Mar 2023 | - | $1.88 M(-3.4%) | $11.03 M(+25.9%) |
| Dec 2022 | $8.77 M | $1.94 M(-74.1%) | $8.77 M(-45.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $7.48 M(-2915.2%) | $16.01 M(+43.1%) |
| Jun 2022 | - | -$265.80 K(-32.1%) | $11.19 M(-42.1%) |
| Mar 2022 | - | -$391.30 K(-104.3%) | $19.31 M(-4.9%) |
| Dec 2021 | $20.31 M(+1746.6%) | $9.19 M(+245.5%) | $20.31 M(+82.6%) |
| Sep 2021 | - | $2.66 M(-66.1%) | $11.13 M(+31.4%) |
| Jun 2021 | - | $7.85 M(+1181.5%) | $8.47 M(+1281.5%) |
| Mar 2021 | - | $612.90 K | $612.90 K |
| Dec 2020 | $1.10 M | - | - |
FAQ
- What is Ensysce Biosciences annual cash flow from financing activities?
- What is the all time high annual CFF for Ensysce Biosciences?
- What is Ensysce Biosciences annual CFF year-on-year change?
- What is Ensysce Biosciences quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Ensysce Biosciences?
- What is Ensysce Biosciences quarterly CFF year-on-year change?
- What is Ensysce Biosciences TTM cash flow from financing activities?
- What is the all time high TTM CFF for Ensysce Biosciences?
- What is Ensysce Biosciences TTM CFF year-on-year change?
What is Ensysce Biosciences annual cash flow from financing activities?
The current annual CFF of ENSC is $8.76 M
What is the all time high annual CFF for Ensysce Biosciences?
Ensysce Biosciences all-time high annual cash flow from financing activities is $20.31 M
What is Ensysce Biosciences annual CFF year-on-year change?
Over the past year, ENSC annual cash flow from financing activities has changed by -$10.00 K (-0.11%)
What is Ensysce Biosciences quarterly cash flow from financing activities?
The current quarterly CFF of ENSC is $4.13 M
What is the all time high quarterly CFF for Ensysce Biosciences?
Ensysce Biosciences all-time high quarterly cash flow from financing activities is $9.19 M
What is Ensysce Biosciences quarterly CFF year-on-year change?
Over the past year, ENSC quarterly cash flow from financing activities has changed by +$2.67 M (+182.71%)
What is Ensysce Biosciences TTM cash flow from financing activities?
The current TTM CFF of ENSC is $11.23 M
What is the all time high TTM CFF for Ensysce Biosciences?
Ensysce Biosciences all-time high TTM cash flow from financing activities is $20.31 M
What is Ensysce Biosciences TTM CFF year-on-year change?
Over the past year, ENSC TTM cash flow from financing activities has changed by +$2.47 M (+28.25%)